{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T13:00:06Z","timestamp":1791378006092,"version":"4.3.2"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T00:00:00Z","timestamp":1727913600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["PHD60I0075"],"award-info":[{"award-number":["PHD60I0075"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004704","name":"National Research Council of Thailand","doi-asserted-by":"publisher","award":["N42A670624"],"award-info":[{"award-number":["N42A670624"]}],"id":[{"id":"10.13039\/501100004704","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The KING PRAJADHIPOK and QUEEN RAMBHAIBARNI MEMORIAL FOUNDATION"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-73339-2","type":"journal-article","created":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T03:52:00Z","timestamp":1727927520000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Development of novel canine phage display-derived neutralizing monoclonal antibody fragments against rabies virus from immunized dogs"],"prefix":"10.1038","volume":"14","author":[{"given":"Apidsada","family":"Chorpunkul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usa","family":"Boonyuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kriengsak","family":"Limkittikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wachiraporn","family":"Saengseesom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wallaya","family":"Phongphaew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iyarath","family":"Putchong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penpitcha","family":"Chankeeree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sirin","family":"Theerawatanasirikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Hajitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Surachet","family":"Benjathummarak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pannamthip","family":"Pitaksajjakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Porntippa","family":"Lekcharoensuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pongrama","family":"Ramasoota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,10,3]]},"reference":[{"key":"73339_CR1","doi-asserted-by":"publisher","first-page":"e0009980","DOI":"10.1371\/journal.pntd.0009980","volume":"15","author":"W Thanapongtharm","year":"2021","unstructured":"Thanapongtharm, W., Suwanpakdee, S., Chumkaeo, A., Gilbert, M. & Wiratsudakul, A. Current characteristics of animal rabies cases in Thailand and relevant risk factors identified by a spatial modeling approach. PLoS Negl. Trop. Dis.15, e0009980. https:\/\/doi.org\/10.1371\/journal.pntd.0009980 (2021).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73339_CR2","doi-asserted-by":"crossref","unstructured":"Niezgoda, M., Hanlon, C. A. & Rupprecht, C. E. Animal rabies. Rabies 163\u2013218 (2003).","DOI":"10.1016\/B978-012379077-4\/50007-9"},{"key":"73339_CR3","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/0042-6822(87)90167-X","volume":"161","author":"B Dietzschold","year":"1987","unstructured":"Dietzschold, B., Tollis, M., Lafon, M., Wunner, W. H. & Koprowski, H. Mechanisms of Rabies virus neutralization by glycoprotein-specific monoclonal antibodies. Virology161, 29\u201336 (1987).","journal-title":"Virology"},{"key":"73339_CR4","doi-asserted-by":"publisher","first-page":"eabp9151","DOI":"10.1126\/sciadv.abp9151","volume":"8","author":"HM Callaway","year":"2022","unstructured":"Callaway, H. M. et al. Structure of the Rabies virus glycoprotein trimer bound to a prefusion-specific neutralizing antibody. Sci. Adv.8, eabp9151. https:\/\/doi.org\/10.1126\/sciadv.abp9151 (2022).","journal-title":"Sci. Adv."},{"key":"73339_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1007\/978-1-4615-2930-9_102","volume":"329","author":"V Flamand","year":"1993","unstructured":"Flamand, V. et al. Vaccination with tumor-antigen-pulsed dendritic cells induces in vivo resistance to a B cell lymphoma. Adv. Exp. Med. Biol.329, 611\u2013616. https:\/\/doi.org\/10.1007\/978-1-4615-2930-9_102 (1993).","journal-title":"Adv. Exp. Med. Biol."},{"key":"73339_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1128\/JVI.62.1.1-7.1988","volume":"62","author":"C Prehaud","year":"1988","unstructured":"Prehaud, C., Coulon, P., LaFay, F., Thiers, C. & Flamand, A. Antigenic site II of the Rabies virus glycoprotein: structure and role in viral virulence. J. Virol.62, 1\u20137. https:\/\/doi.org\/10.1128\/JVI.62.1.1-7.1988 (1988).","journal-title":"J. Virol."},{"key":"73339_CR7","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1128\/JVI.53.3.926-934.1985","volume":"53","author":"I Seif","year":"1985","unstructured":"Seif, I., Coulon, P., Rollin, P. E. & Flamand, A. Rabies virulence: effect on pathogenicity and sequence characterization of Rabies virus mutations affecting antigenic site III of the glycoprotein. J. Virol.53, 926\u2013934. https:\/\/doi.org\/10.1128\/JVI.53.3.926-934.1985 (1985).","journal-title":"J. Virol."},{"key":"73339_CR8","doi-asserted-by":"publisher","unstructured":"Yang, F. et al. Structural analysis of rabies virus glycoprotein reveals pH-dependent conformational changes and interactions with a neutralizing antibody. Cell Host Microbe27, 441\u2013453. https:\/\/doi.org\/10.1016\/j.chom.2019.12.012  (2020).","DOI":"10.1016\/j.chom.2019.12.012"},{"key":"73339_CR9","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1111\/j.1863-2378.2012.01489.x","volume":"59","author":"Tenzin","year":"2012","unstructured":"Tenzin & Ward, M. Review of rabies epidemiology and control in South, South East and East Asia: past, present and prospects for elimination. Zoonoses Public. Health59, 451\u2013467 (2012).","journal-title":"Zoonoses Public. Health"},{"key":"73339_CR10","unstructured":"World Health Organization (WHO) (2020)."},{"key":"73339_CR11","doi-asserted-by":"publisher","first-page":"e0003709","DOI":"10.1371\/journal.pntd.0003709","volume":"9","author":"K Hampson","year":"2015","unstructured":"Hampson, K. et al. Estimating the global burden of endemic canine rabies. PLoS Negl. Trop. Dis.9, e0003709 (2015).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73339_CR12","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1016\/j.cimid.2012.10.008","volume":"36","author":"SE Townsend","year":"2013","unstructured":"Townsend, S. E. et al. Surveillance guidelines for disease elimination: a case study of canine rabies. Comp. Immunol. Microbiol. Infect. Dis.36, 249\u2013261 (2013).","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"73339_CR13","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fvets.2017.00052","volume":"4","author":"T Leung","year":"2017","unstructured":"Leung, T. & Davis, S. A. Rabies vaccination targets for stray dog populations. Front. Veterinary Sci.4, 52 (2017).","journal-title":"Front. Veterinary Sci."},{"key":"73339_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.prevetmed.2006.11.003","volume":"78","author":"S Kasempimolporn","year":"2007","unstructured":"Kasempimolporn, S. et al. Prevalence of Rabies virus infection and rabies antibody in stray dogs: A survey in Bangkok, Thailand. Prev. Vet. Med.78, 325\u2013332 (2007).","journal-title":"Prev. Vet. Med."},{"key":"73339_CR15","unstructured":"Rupprecht, C. E., Fooks, A. R. & Abela-Ridder, B. Laboratory Techniques in Rabies Vol. 1 (WHO, 2018)."},{"key":"73339_CR16","doi-asserted-by":"publisher","first-page":"699352","DOI":"10.3389\/fvets.2021.699352","volume":"8","author":"S Premashthira","year":"2021","unstructured":"Premashthira, S. et al. The impact of socioeconomic factors on knowledge, attitudes, and practices of dog owners on dog rabies control in Thailand. Front. Veterinary Sci.8, 699352 (2021).","journal-title":"Front. Veterinary Sci."},{"key":"73339_CR17","first-page":"243","volume":"20","author":"XL Zhao","year":"2004","unstructured":"Zhao, X. L., Yin, J., Wang, H., Jiang, M. & Hou, X. J. Construction of human phage-displayed scFv library and selection of the ScFv against Rabies virus. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi20, 243\u2013247 (2004).","journal-title":"Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi"},{"key":"73339_CR18","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1007\/s00253-012-4171-4","volume":"96","author":"L Sun","year":"2012","unstructured":"Sun, L. et al. Generation and characterization of neutralizing human recombinant antibodies against antigenic site II of Rabies virus glycoprotein. Appl. Microbiol. Biotechnol.96, 357\u2013366. https:\/\/doi.org\/10.1007\/s00253-012-4171-4 (2012).","journal-title":"Appl. Microbiol. Biotechnol."},{"issue":"Suppl 1","key":"73339_CR19","doi-asserted-by":"publisher","first-page":"A132","DOI":"10.1016\/j.vaccine.2018.11.004","volume":"37","author":"E Sparrow","year":"2019","unstructured":"Sparrow, E. et al. Recent advances in the development of monoclonal antibodies for rabies post exposure prophylaxis: a review of the current status of the clinical development pipeline. Vaccine37(Suppl 1), A132\u2013A139. https:\/\/doi.org\/10.1016\/j.vaccine.2018.11.004 (2019).","journal-title":"Vaccine"},{"key":"73339_CR20","unstructured":"Serum Institute of India PVT. LTD (2018)."},{"key":"73339_CR21","doi-asserted-by":"publisher","unstructured":"Yumoto, K. et al. Characterization of single-chain fv fragments of neutralizing antibodies to rabies virus glycoprotein. Viruses13https:\/\/doi.org\/10.3390\/v13112311 (2021).","DOI":"10.3390\/v13112311"},{"key":"73339_CR22","doi-asserted-by":"publisher","first-page":"e0004902","DOI":"10.1371\/journal.pntd.0004902","volume":"10","author":"S Terryn","year":"2016","unstructured":"Terryn, S., Francart, A., Rommelaere, H., Stortelers, C. & Van Gucht, S. Post-exposure treatment with anti-rabies VHH and vaccine significantly improves Protection of mice from Lethal rabies infection. PLoS Negl. Trop. Dis.10, e0004902. https:\/\/doi.org\/10.1371\/journal.pntd.0004902 (2016).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73339_CR23","first-page":"393","volume":"32","author":"L Sun","year":"2016","unstructured":"Sun, L., Liu, Y., Li, C., Li, D. & Liang, M. Generation of human ScFv antibodies for antigenic site III of rabies virus glycoprotein from antibody-phage libraries by Chain Shuffling. Bing Du Xue Bao32, 393\u2013398 (2016).","journal-title":"Bing Du Xue Bao"},{"key":"73339_CR24","doi-asserted-by":"publisher","first-page":"2195517","DOI":"10.1080\/19420862.2023.2195517","volume":"15","author":"LE Boucher","year":"2023","unstructured":"Boucher, L. E. et al. Stapling scFv for multispecific biotherapeutics of superior properties. MAbs15, 2195517. https:\/\/doi.org\/10.1080\/19420862.2023.2195517 (2023).","journal-title":"MAbs"},{"key":"73339_CR25","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.jmb.2004.08.019","volume":"343","author":"KS Midelfort","year":"2004","unstructured":"Midelfort, K. S. et al. Substantial energetic improvement with minimal structural perturbation in a high affinity mutant antibody. J. Mol. Biol.343, 685\u2013701. https:\/\/doi.org\/10.1016\/j.jmb.2004.08.019 (2004).","journal-title":"J. Mol. Biol."},{"key":"73339_CR26","doi-asserted-by":"publisher","first-page":"348","DOI":"10.30699\/ijmm.14.4.348","volume":"14","author":"N Miandehi","year":"2020","unstructured":"Miandehi, N., Bidoki, S., Ajorloo, M. & Gholami, A. Change in the Basic structure of the rabies Virus Glycoprotein by Reverse Genetics. Iran. J. Med. Microbiol.14, 348\u2013360. https:\/\/doi.org\/10.30699\/ijmm.14.4.348 (2020).","journal-title":"Iran. J. Med. Microbiol."},{"key":"73339_CR27","doi-asserted-by":"crossref","unstructured":"Shi, C. et al. Research progress on neutralizing epitopes and antibodies for the rabies virus. Infect. Med. (2022).","DOI":"10.1016\/j.imj.2022.09.003"},{"key":"73339_CR28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1348-0421.2008.00016.x","volume":"52","author":"XL Zhao","year":"2008","unstructured":"Zhao, X. L. et al. Generation and characterization of human monoclonal antibodies to G5, a linear neutralization epitope on glycoprotein of Rabies virus, by phage display technology. Microbiol. Immunol.52, 89\u201393. https:\/\/doi.org\/10.1111\/j.1348-0421.2008.00016.x (2008).","journal-title":"Microbiol. Immunol."},{"key":"73339_CR29","unstructured":"World Health Organization (WHO) (2018)."},{"key":"73339_CR30","unstructured":"World Health Organization (WHO) (2014)."},{"key":"73339_CR31","doi-asserted-by":"publisher","first-page":"5822","DOI":"10.1016\/j.vaccine.2021.08.066","volume":"39","author":"JB McClain","year":"2021","unstructured":"McClain, J. B., Chuang, A., Reid, C., Moore, S. M. & Tsao, E. Rabies virus neutralizing activity, pharmacokinetics, and safety of the monoclonal antibody mixture SYN023 in combination with rabies vaccination: results of a phase 2, randomized, blinded, controlled trial. Vaccine39, 5822\u20135830. https:\/\/doi.org\/10.1016\/j.vaccine.2021.08.066 (2021).","journal-title":"Vaccine"},{"key":"73339_CR32","unstructured":"Bunn, T., Ridpath, H. & Beard, P. The Relationship Between Rabies Antibody Titers in Dogs and Cats and Protection from Challenge (Centers Disease Control, 1984)."},{"key":"73339_CR33","unstructured":"Rabies, F. Developing monoclonal antibody cocktails for the passive immunization component of post-exposure prophylaxis. Guidance for Industry (2021)."},{"key":"73339_CR34","doi-asserted-by":"publisher","first-page":"2026713","DOI":"10.1080\/21645515.2022.2026713","volume":"18","author":"L Fan","year":"2022","unstructured":"Fan, L., Zhang, L., Li, J. & Zhu, F. Advances in the progress of monoclonal antibodies for rabies. Hum. Vaccines Immunother.18, 2026713 (2022).","journal-title":"Hum. Vaccines Immunotherapeutics"},{"key":"73339_CR35","unstructured":"World Health Organization (WHO). Rabies Vaccines and Immunoglobulins: WHO Position: Summary of 2017 Updates (WHO, 2018)."},{"key":"73339_CR36","doi-asserted-by":"publisher","unstructured":"Andris-Widhopf, J., Steinberger, P., Fuller, R., Rader, C. & Barbas, C. F. Generation of human Fab antibody libraries: PCR amplification and assembly of light- and heavy-chain coding sequences. Cold Spring Harb Protoc. https:\/\/doi.org\/10.1101\/pdb.prot065565 (2011).","DOI":"10.1101\/pdb.prot065565"},{"key":"73339_CR37","unstructured":"Pruksametanan, N. Production of human monoclonal antibodies against rabies virus using phage display technology (Doctoral dissertation) (School of Biotechnology Institute of Agricultural Technology, Suranaree University of Technology, 2013)."},{"key":"73339_CR38","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/1472-6750-9-6","volume":"9","author":"P Pansri","year":"2009","unstructured":"Pansri, P., Jaruseranee, N., Rangnoi, K., Kristensen, P. & Yamabhai, M. A compact phage display human scFv library for selection of antibodies to a wide variety of antigens. BMC Biotechnol.9, 6. https:\/\/doi.org\/10.1186\/1472-6750-9-6 (2009).","journal-title":"BMC Biotechnol."},{"key":"73339_CR39","doi-asserted-by":"publisher","unstructured":"Aavula, S. M. et al. Generation and characterization of an scFv Directed against Site II of rabies glycoprotein. Biotechnol Res Int  652147. https:\/\/doi.org\/10.4061\/2011\/652147 (2011).","DOI":"10.4061\/2011\/652147"},{"key":"73339_CR40","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1472-6750-12-87","volume":"12","author":"R Kumar","year":"2012","unstructured":"Kumar, R. et al. A novel strategy for efficient production of anti-V3 human scFvs against HIV-1 clade C. BMC Biotechnol.12, 87. https:\/\/doi.org\/10.1186\/1472-6750-12-87 (2012).","journal-title":"BMC Biotechnol."},{"key":"73339_CR41","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.vetimm.2010.07.026","volume":"139","author":"A Braganza","year":"2011","unstructured":"Braganza, A. et al. Generation and validation of canine single chain variable fragment phage display libraries. Vet. Immunol. Immunopathol.139, 27\u201340. https:\/\/doi.org\/10.1016\/j.vetimm.2010.07.026 (2011).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"73339_CR42","first-page":"360","volume":"7","author":"YL Chiang","year":"1989","unstructured":"Chiang, Y. L., Sheng-Dong, R., Brow, M. A. & Larrick, J. W. Direct cDNA cloning of the rearranged immunoglobulin variable region. Biotechniques7, 360\u2013366 (1989).","journal-title":"Biotechniques"},{"key":"73339_CR43","doi-asserted-by":"publisher","first-page":"1156","DOI":"10.4049\/jimmunol.157.3.1156","volume":"157","author":"HI Yamanaka","year":"1996","unstructured":"Yamanaka, H. I. & Inoue, T. Ikeda-Tanaka, O. Chicken monoclonal antibody isolated by a phage display system. J. Immunol.157, 1156\u20131162 (1996).","journal-title":"J. Immunol."},{"key":"73339_CR44","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0022-1759(95)00143-x","volume":"186","author":"EL Davies","year":"1995","unstructured":"Davies, E. L. et al. Selection of specific phage-display antibodies using libraries derived from chicken immunoglobulin genes. J. Immunol. Methods186, 125\u2013135. https:\/\/doi.org\/10.1016\/0022-1759(95)00143-x (1995).","journal-title":"J. Immunol. Methods"},{"key":"73339_CR45","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/s0022-1759(00)00221-0","volume":"242","author":"J Andris-Widhopf","year":"2000","unstructured":"Andris-Widhopf, J., Rader, C., Steinberger, P., Fuller, R. & Barbas, C. F. Methods for the generation of chicken monoclonal antibody fragments by phage display. J. Immunol. Methods242, 159\u2013181. https:\/\/doi.org\/10.1016\/s0022-1759(00)00221-0 (2000).","journal-title":"J. Immunol. Methods"},{"key":"73339_CR46","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jim.2007.12.014","volume":"332","author":"J Sepulveda","year":"2008","unstructured":"Sepulveda, J. & Shoemaker, C. B. Design and testing of PCR primers for the construction of scFv libraries representing the immunoglobulin repertoire of rats. J. Immunol. Methods332, 92\u2013102. https:\/\/doi.org\/10.1016\/j.jim.2007.12.014 (2008).","journal-title":"J. Immunol. Methods"},{"key":"73339_CR47","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nbt0395-255","volume":"13","author":"R Ridder","year":"1995","unstructured":"Ridder, R., Schmitz, R., Legay, F. & Gram, H. Generation of rabbit monoclonal antibody fragments from a combinatorial phage display library and their production in the yeast Pichia pastoris. Biotechnol. (N Y)13, 255\u2013260. https:\/\/doi.org\/10.1038\/nbt0395-255 (1995).","journal-title":"Biotechnol. (N Y)"},{"key":"73339_CR48","doi-asserted-by":"publisher","first-page":"36073","DOI":"10.1074\/jbc.M002765200","volume":"275","author":"P Steinberger","year":"2000","unstructured":"Steinberger, P., Sutton, J. K., Rader, C., Elia, M. & Barbas, C. F. Generation and characterization of a recombinant human CCR5-specific antibody. A phage display approach for rabbit antibody humanization. J. Biol. Chem.275, 36073\u201336078. https:\/\/doi.org\/10.1074\/jbc.M002765200 (2000).","journal-title":"J. Biol. Chem."},{"key":"73339_CR49","unstructured":"Scripps Research (2020)."},{"key":"73339_CR50","doi-asserted-by":"publisher","unstructured":"Rader, C., Cheresh, D. A. & Barbas, C. F. 3rd. A phage display approach for rapid antibody humanization: designed combinatorial V gene libraries. Proc. Natl. Acad. Sci. USA95, 8910\u20138915. https:\/\/doi.org\/10.1073\/pnas.95.15.8910 (1998)","DOI":"10.1073\/pnas.95.15.8910"},{"key":"73339_CR51","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/s0022-2836(02)01232-9","volume":"325","author":"M Popkov","year":"2003","unstructured":"Popkov, M. et al. Rabbit immune repertoires as sources for therapeutic monoclonal antibodies: the impact of kappa allotype-correlated variation in cysteine content on antibody libraries selected by phage display. J. Mol. Biol.325, 325\u2013335. https:\/\/doi.org\/10.1016\/s0022-2836(02)01232-9 (2003).","journal-title":"J. Mol. Biol."},{"key":"73339_CR52","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/s41421-021-00295-w","volume":"7","author":"Y Pan","year":"2021","unstructured":"Pan, Y. et al. Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries. Cell Discov.7, 57. https:\/\/doi.org\/10.1038\/s41421-021-00295-w (2021).","journal-title":"Cell. Discov"},{"key":"73339_CR53","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1046\/j.1365-2249.2001.01515.x","volume":"125","author":"K Ray","year":"2001","unstructured":"Ray, K., Embleton, M. J., Jailkhani, B. L., Bhan, M. K. & Kumar, R. Selection of single chain variable fragments (scFv) against the glycoprotein antigen of the Rabies virus from a human synthetic scFv phage display library and their fusion with the fc region of human IgG1. Clin. Exp. Immunol.125, 94\u2013101. https:\/\/doi.org\/10.1046\/j.1365-2249.2001.01515.x (2001).","journal-title":"Clin. Exp. Immunol."},{"key":"73339_CR54","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1111\/j.1348-0421.2005.tb03735.x","volume":"49","author":"T Ando","year":"2005","unstructured":"Ando, T., Yamashiro, T., Takita-Sonoda, Y., Mannen, K. & Nishizono, A. Construction of human Fab library and isolation of monoclonal fabs with rabies virus-neutralizing ability. Microbiol. Immunol.49, 311\u2013322. https:\/\/doi.org\/10.1111\/j.1348-0421.2005.tb03735.x (2005).","journal-title":"Microbiol. Immunol."},{"key":"73339_CR55","doi-asserted-by":"publisher","first-page":"2131","DOI":"10.1002\/eji.200526134","volume":"35","author":"RA Kramer","year":"2005","unstructured":"Kramer, R. A. et al. The human antibody repertoire specific for Rabies virus glycoprotein as selected from immune libraries. Eur. J. Immunol.35, 2131\u20132145. https:\/\/doi.org\/10.1002\/eji.200526134 (2005).","journal-title":"Eur. J. Immunol."},{"key":"73339_CR56","doi-asserted-by":"publisher","first-page":"e19848","DOI":"10.1371\/journal.pone.0019848","volume":"6","author":"X Liu","year":"2011","unstructured":"Liu, X. et al. Characterization of a human antibody fragment Fab and its calcium phosphate nanoparticles that inhibit rabies virus infection with vaccine. PLoS ONE6, e19848. https:\/\/doi.org\/10.1371\/journal.pone.0019848 (2011).","journal-title":"PLoS One"},{"key":"73339_CR57","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.bbrc.2010.04.040","volume":"395","author":"P Pitaksajjakul","year":"2010","unstructured":"Pitaksajjakul, P. et al. Fab MAbs specific to HA of influenza virus with H5N1 neutralizing activity selected from immunized chicken phage library. Biochem. Biophys. Res. Commun.395, 496\u2013501. https:\/\/doi.org\/10.1016\/j.bbrc.2010.04.040 (2010).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"73339_CR58","doi-asserted-by":"publisher","unstructured":"Lee, C. H. et al. The bottlenecks of preparing Virus particles by size exclusion for antibody generation. Int. J. Mol. Sci.. https:\/\/doi.org\/10.3390\/ijms232112967 (2022).","DOI":"10.3390\/ijms232112967"},{"key":"73339_CR59","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1128\/IAI.70.8.4158-4164.2002","volume":"70","author":"N Reiche","year":"2002","unstructured":"Reiche, N. et al. Generation and characterization of human monoclonal scFv antibodies against Helicobacter pylori antigens. Infect. Immun.70, 4158\u20134164. https:\/\/doi.org\/10.1128\/IAI.70.8.4158-4164.2002 (2002).","journal-title":"Infect. Immun."},{"key":"73339_CR60","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ab.2018.05.009","volume":"555","author":"W Lee","year":"2018","unstructured":"Lee, W., Syed, A. A., Leow, C. Y., Tan, S. C. & Leow, C. H. Isolation and characterization of a novel anti-salbutamol chicken scFv for human doping urinalysis. Anal. Biochem.555, 81\u201393. https:\/\/doi.org\/10.1016\/j.ab.2018.05.009 (2018).","journal-title":"Anal. Biochem."},{"key":"73339_CR61","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1007\/s00253-021-11722-z","volume":"106","author":"F Wang","year":"2022","unstructured":"Wang, F. et al. Generation and functional analysis of single chain variable fragments (scFvs) targeting the nucleocapsid protein of porcine epidemic diarrhea virus. Appl. Microbiol. Biotechnol.106, 995\u20131009. https:\/\/doi.org\/10.1007\/s00253-021-11722-z (2022).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"73339_CR62","first-page":"575","volume":"30","author":"C Li","year":"2010","unstructured":"Li, C. et al. Construction and screening of human immunized phage-display antibody libraries against Rabies virus. Acta Univ. Med. Nanjing (Natural Sci)30, 575\u2013578 (2010).","journal-title":"Acta Univ. Med. Nanjing (Natural Sci)"},{"key":"73339_CR63","doi-asserted-by":"publisher","first-page":"e17665","DOI":"10.1371\/journal.pone.0017665","volume":"6","author":"A Hultberg","year":"2011","unstructured":"Hultberg, A. et al. Llama-derived single domain antibodies to build multivalent, superpotent and broadened neutralizing anti-viral molecules. PLoS One. 6, e17665. https:\/\/doi.org\/10.1371\/journal.pone.0017665 (2011).","journal-title":"PLoS One"},{"key":"73339_CR64","unstructured":"Zhang, Y. In MAbs. 2213793 (Taylor & Francis)."},{"key":"73339_CR65","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1016\/j.vetimm.2010.04.011","volume":"137","author":"Y Bao","year":"2010","unstructured":"Bao, Y., Guo, Y., Xiao, S. & Zhao, Z. Molecular characterization of the VH repertoire in Canis familiaris. Vet. Immunol. Immunopathol.137, 64\u201375. https:\/\/doi.org\/10.1016\/j.vetimm.2010.04.011 (2010).","journal-title":"Vet. Immunol. Immunopathol."},{"key":"73339_CR66","unstructured":"Bernat, N. V. Definition of Immunoglobulin Germline Genes by Next Generation Sequencing for Studies of Antigen-Specific B Cell Responses (Karolinska Institutet (Sweden), 2019)."},{"key":"73339_CR67","doi-asserted-by":"publisher","first-page":"e0270710","DOI":"10.1371\/journal.pone.0270710","volume":"17","author":"JN Cullen","year":"2022","unstructured":"Cullen, J. N. et al. Development and application of a next-generation sequencing protocol and bioinformatics pipeline for the comprehensive analysis of the canine immunoglobulin repertoire. PLoS ONE17, e0270710. https:\/\/doi.org\/10.1371\/journal.pone.0270710 (2022).","journal-title":"PLoS One"},{"key":"73339_CR68","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1016\/j.molimm.2014.01.010","volume":"59","author":"SC Steiniger","year":"2014","unstructured":"Steiniger, S. C. et al. Fundamental characteristics of the expressed immunoglobulin VH and VL repertoire in different canine breeds in comparison with those of humans and mice. Mol. Immunol.59, 71\u201378. https:\/\/doi.org\/10.1016\/j.molimm.2014.01.010 (2014).","journal-title":"Mol. Immunol."},{"key":"73339_CR69","doi-asserted-by":"publisher","first-page":"12918","DOI":"10.1021\/bi9810407","volume":"37","author":"KM Arndt","year":"1998","unstructured":"Arndt, K. M., M\u00fcller, K. M. & Pl\u00fcckthun, A. Factors influencing the dimer to monomer transition of an antibody single-chain fv fragment. Biochemistry37, 12918\u201312926. https:\/\/doi.org\/10.1021\/bi9810407 (1998).","journal-title":"Biochemistry"},{"key":"73339_CR70","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/S0022-1759(99)00157-X","volume":"231","author":"PJ Hudson","year":"1999","unstructured":"Hudson, P. J. & Kortt, A. A. High avidity scFv multimers; diabodies and triabodies. J. Immunol. Methods231, 177\u2013189 (1999).","journal-title":"J. Immunol. Methods"},{"key":"73339_CR71","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/S0014-5793(99)00713-9","volume":"453","author":"F Le Gall","year":"1999","unstructured":"Le Gall, F., Kipriyanov, S. M., Moldenhauer, G. & Little, M. Di-, tri-and tetrameric single chain fv antibody fragments against human CD19: effect of valency on cell binding. FEBS Lett.453, 164\u2013168 (1999).","journal-title":"FEBS Lett."},{"key":"73339_CR72","doi-asserted-by":"publisher","first-page":"5449","DOI":"10.1038\/s41598-022-09324-4","volume":"12","author":"M Arslan","year":"2022","unstructured":"Arslan, M. et al. Effect of non-repetitive linker on in vitro and in vivo properties of an anti-VEGF scFv. Sci. Rep.12, 5449 (2022).","journal-title":"Sci. Rep."},{"key":"73339_CR73","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1016\/j.molimm.2006.05.009","volume":"44","author":"V Quintero-Hern\u00e1ndez","year":"2007","unstructured":"Quintero-Hern\u00e1ndez, V. et al. The change of the scFv into the Fab format improves the stability and in vivo toxin neutralization capacity of recombinant antibodies. Mol. Immunol.44, 1307\u20131315. https:\/\/doi.org\/10.1016\/j.molimm.2006.05.009 (2007).","journal-title":"Mol. Immunol."},{"key":"73339_CR74","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/j.jmb.2005.01.053","volume":"347","author":"D R\u00f6thlisberger","year":"2005","unstructured":"R\u00f6thlisberger, D., Honegger, A. & Pl\u00fcckthun, A. Domain interactions in the Fab Fragment: A comparative evaluation of the single-chain fv and Fab Format Engineered with Variable domains of different Stability. J. Mol. Biol.347, 773\u2013789. https:\/\/doi.org\/10.1016\/j.jmb.2005.01.053 (2005).","journal-title":"J. Mol. Biol."},{"key":"73339_CR75","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1016\/j.jbiotec.2009.09.022","volume":"144","author":"XL Zhao","year":"2009","unstructured":"Zhao, X. L. et al. Selection and affinity maturation of human antibodies against Rabies virus from a scFv gene library using ribosome display. J. Biotechnol.144, 253\u2013258. https:\/\/doi.org\/10.1016\/j.jbiotec.2009.09.022 (2009).","journal-title":"J. Biotechnol."},{"key":"73339_CR76","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1371\/journal.pntd.0000542","volume":"3","author":"T Muller","year":"2009","unstructured":"Muller, T. et al. Development of a mouse monoclonal antibody cocktail for post-exposure rabies prophylaxis in humans. PLoS Negl. Trop. Dis.3, e542. https:\/\/doi.org\/10.1371\/journal.pntd.0000542 (2009).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73339_CR77","doi-asserted-by":"publisher","first-page":"e0256779","DOI":"10.1371\/journal.pone.0256779","volume":"16","author":"PK Kim","year":"2021","unstructured":"Kim, P. K. et al. A broad-spectrum and highly potent human monoclonal antibody cocktail for rabies prophylaxis. PLoS ONE16, e0256779. https:\/\/doi.org\/10.1371\/journal.pone.0256779 (2021).","journal-title":"PLoS One"},{"key":"73339_CR78","doi-asserted-by":"publisher","first-page":"596","DOI":"10.1038\/s41467-020-14398-7","volume":"11","author":"J Hellert","year":"2020","unstructured":"Hellert, J. et al. Structure of the prefusion-locking broadly neutralizing antibody RVC20 bound to the Rabies virus glycoprotein. Nat. Commun.11, 596. https:\/\/doi.org\/10.1038\/s41467-020-14398-7 (2020).","journal-title":"Nat. Commun."},{"key":"73339_CR79","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1093\/cid\/cix791","volume":"66","author":"NJ Gogtay","year":"2018","unstructured":"Gogtay, N. J. et al. Comparison of a Novel human rabies monoclonal antibody to human rabies immunoglobulin for Postexposure Prophylaxis: a phase 2\/3, Randomized, Single-Blind, Noninferiority, controlled study. Clin. Infect. Dis.66, 387\u2013395. https:\/\/doi.org\/10.1093\/cid\/cix791 (2018).","journal-title":"Clin. Infect. Dis."},{"key":"73339_CR80","doi-asserted-by":"publisher","first-page":"5922","DOI":"10.1016\/j.vaccine.2008.08.050","volume":"26","author":"AB Bakker","year":"2008","unstructured":"Bakker, A. B. et al. First administration to humans of a monoclonal antibody cocktail against Rabies virus: safety, tolerability, and neutralizing activity. Vaccine26, 5922\u20135927. https:\/\/doi.org\/10.1016\/j.vaccine.2008.08.050 (2008).","journal-title":"Vaccine"},{"key":"73339_CR81","first-page":"399","volume":"32","author":"L Sun","year":"2016","unstructured":"Sun, L., Liu, Y., Li, C., Li, D. & Liang, M. [Development of recombinant human monoclonal antibody cocktail for post-exposure rabies Prophylaxis]. Bing Du Xue Bao32, 399\u2013403 (2016).","journal-title":"Bing Du Xue Bao"},{"key":"73339_CR82","doi-asserted-by":"publisher","first-page":"e0006133","DOI":"10.1371\/journal.pntd.0006133","volume":"11","author":"TY Chao","year":"2017","unstructured":"Chao, T. Y. et al. SYN023, a novel humanized monoclonal antibody cocktail, for post-exposure prophylaxis of rabies. PLoS Negl. Trop. Dis.11, e0006133. https:\/\/doi.org\/10.1371\/journal.pntd.0006133 (2017).","journal-title":"PLoS Negl. Trop. Dis."},{"key":"73339_CR83","doi-asserted-by":"publisher","first-page":"407","DOI":"10.15252\/emmm.201505986","volume":"8","author":"P De Benedictis","year":"2016","unstructured":"De Benedictis, P. et al. Development of broad-spectrum human monoclonal antibodies for rabies post-exposure prophylaxis. EMBO Mol. Med.8, 407\u2013421. https:\/\/doi.org\/10.15252\/emmm.201505986 (2016).","journal-title":"EMBO Mol. Med."},{"key":"73339_CR84","doi-asserted-by":"publisher","first-page":"5897","DOI":"10.1016\/j.vaccine.2013.09.038","volume":"31","author":"AB Papaneri","year":"2013","unstructured":"Papaneri, A. B., Wirblich, C., Marissen, W. E. & Schnell, M. J. Alanine scanning of the Rabies virus glycoprotein antigenic site III using recombinant rabies virus: implication for post-exposure treatment. Vaccine31, 5897\u20135902. https:\/\/doi.org\/10.1016\/j.vaccine.2013.09.038 (2013).","journal-title":"Vaccine"},{"key":"73339_CR85","doi-asserted-by":"publisher","unstructured":"Chao, T. Y., Zhang, S. F., Chen, L., Tsao, E. & Rupprecht, C. E. In vivo efficacy of SYN023, an anti-rabies monoclonal antibody cocktail, in Post-exposure Prophylaxis Animal models. Trop. Med. Infect. Dis.5https:\/\/doi.org\/10.3390\/tropicalmed5010031 (2020).","DOI":"10.3390\/tropicalmed5010031"},{"key":"73339_CR86","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/0042-6822(89)90122-0","volume":"172","author":"C Tuffereau","year":"1989","unstructured":"Tuffereau, C. et al. Arginine or lysine in position 333 of ERA and CVS glycoprotein is necessary for rabies virulence in adult mice. Virology172, 206\u2013212. https:\/\/doi.org\/10.1016\/0042-6822(89)90122-0 (1989).","journal-title":"Virology"},{"key":"73339_CR87","doi-asserted-by":"publisher","first-page":"e0292833","DOI":"10.1371\/journal.pone.0292833","volume":"18","author":"N Tanwattana","year":"2023","unstructured":"Tanwattana, N. et al. Human BST2 inhibits Rabies virus release independently of cysteine-linked dimerization and asparagine-linked glycosylation. Plos ONE18, e0292833 (2023).","journal-title":"Plos One"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73339-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73339-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,3]],"date-time":"2024-10-03T03:53:15Z","timestamp":1727927595000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-73339-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10,3]]},"references-count":87,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["73339"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-73339-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10,3]]},"assertion":[{"value":"23 May 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 September 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 October 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"22939"}}